Exelon Co. (NASDAQ:EXC – Get Free Report) EVP Colette D. Honorable sold 1,463 shares of the business’s stock in a transaction dated Monday, February 3rd. The shares were sold at an average price of $40.57, for a total value of $59,353.91. Following the completion of the sale, the executive vice president now directly owns 2,271 shares of the company’s stock, valued at approximately $92,134.47. This represents a 39.18 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.
Exelon Price Performance
Shares of NASDAQ:EXC opened at $41.12 on Friday. The firm’s 50 day moving average is $38.30 and its two-hundred day moving average is $38.65. The firm has a market capitalization of $41.32 billion, a P/E ratio of 16.92, a PEG ratio of 2.66 and a beta of 0.56. The company has a current ratio of 1.09, a quick ratio of 0.97 and a debt-to-equity ratio of 1.66. Exelon Co. has a 52 week low of $33.35 and a 52 week high of $41.26.
Wall Street Analyst Weigh In
EXC has been the subject of a number of research analyst reports. Evercore ISI upgraded Exelon from an “in-line” rating to an “outperform” rating and boosted their price target for the company from $43.00 to $44.00 in a report on Tuesday, January 21st. Scotiabank boosted their target price on shares of Exelon from $40.00 to $42.00 and gave the company a “sector perform” rating in a research note on Thursday, December 12th. Barclays decreased their price target on shares of Exelon from $44.00 to $42.00 and set an “overweight” rating for the company in a report on Wednesday, January 22nd. Morgan Stanley dropped their price objective on shares of Exelon from $46.00 to $44.00 and set an “equal weight” rating on the stock in a research note on Friday, November 22nd. Finally, Guggenheim upgraded Exelon from a “neutral” rating to a “buy” rating in a research note on Thursday, January 23rd. Five equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $43.13.
Institutional Trading of Exelon
Large investors have recently added to or reduced their stakes in the business. Foundations Investment Advisors LLC increased its stake in shares of Exelon by 3.5% during the third quarter. Foundations Investment Advisors LLC now owns 7,533 shares of the company’s stock valued at $305,000 after acquiring an additional 255 shares during the period. Harbor Capital Advisors Inc. increased its position in shares of Exelon by 1.0% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 28,392 shares of the company’s stock valued at $1,151,000 after purchasing an additional 274 shares during the period. Rosenberg Matthew Hamilton raised its stake in shares of Exelon by 12.6% in the 4th quarter. Rosenberg Matthew Hamilton now owns 2,457 shares of the company’s stock worth $92,000 after buying an additional 275 shares in the last quarter. Ballentine Partners LLC lifted its holdings in shares of Exelon by 2.1% in the third quarter. Ballentine Partners LLC now owns 13,922 shares of the company’s stock valued at $565,000 after buying an additional 285 shares during the period. Finally, Wesbanco Bank Inc. boosted its stake in Exelon by 3.1% during the fourth quarter. Wesbanco Bank Inc. now owns 9,951 shares of the company’s stock valued at $375,000 after buying an additional 296 shares in the last quarter. 80.92% of the stock is currently owned by institutional investors and hedge funds.
About Exelon
Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.
See Also
- Five stocks we like better than Exelon
- What is a SEC Filing?
- Price Plunge in Roblox Presents Opportunity for Robust Gains
- How to Invest in Biotech Stocks
- Billions in Buybacks: 4 Stocks Rewarding Shareholders Now
- How to Invest in Insurance Companies: A GuideĀ
- 3 Steel Stocks to Gain Strength as Tariffs Reshape the Market
Receive News & Ratings for Exelon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exelon and related companies with MarketBeat.com's FREE daily email newsletter.